• Clorazepate, Urine
  • CDKN1C Gene Mutation Analysis
  • Levorphanol, Urine
  • Alpha 1 Antitrypsin, Serum
  • Human Papillomavirus (HPV), High-Risk, DNA In Situ Hybridization
  • Acanthamoeba and Naegleria Culture and Stains, Corneal Scraping
  • Pseudocholinesterase, Total, Serum
  • Immunoglobulin Heavy and Light Chain (HLC) Pairs, IgM Kappa and IgM Lambda
  • Myeloid Differentiation Primary Response 88 (MYD88) Gene Mutation Analysis
  • Anti-Neutrophil Cytoplasmic Antibody (ANCA), IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /ROMA Score for Ovarian Cancer Risk Assessment
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • Panel Test Components
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • Panel Test Components

ROMA Score for Ovarian Cancer Risk Assessment
Medical Test

LOINC
Access to ROMA Score for Ovarian Cancer Risk Assessment is restricted.